Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Akorn Enters Five-Year Ophthalmology Pact | Contract Pharma
Breaking News

Akorn Enters Five-Year Ophthalmology Pact

Akorn, Inc. has entered into a five-year contract manufacturing supply  agreement with an undisclosed drug company. Akorn will be responsible for the manufacturing and supply of the ophthalmic drug product. Akorn is the ANDA holder and expects to begin supplying the product in the first half of 2009.

Arthur S. Przybyl, Akorn’s president and chief executive officer stated, “We are very pleased to have been selected as the contract manufacturer for this ophthalmic product. The completion of this agreement represents the fifth new ophthalmic partnership in 2008 for  our contract manufacturing business. We continue to seek opportunities in ophthalmics, liquid and lyophilized injectable products in order to expand our contract pharmaceutical business segment revenues.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters